1354 Anti-CCR8 antibody CHS-114 (SRF114) depletes tumor-infiltrating regulatory T cells in dissociated tumors from patients with head and neck squamous cell carcinoma

• Yu Yang,
• Ricard Masia,
• Yue Ren,
• Jonathan A Hill,
• Vito J Palombella,
• Robert R Haines,
• Marisella Panduro,
• James F Mohan

Affiliations

Yu Yang

Department of Vascular and Thyroid Surgery, The First Affiliated Hospital of China Medical University, Shenyang, Liaoning, China

Ricard Masia

6 Department of Pathology, Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA

Yue Ren

1 Department of Gastroenterology, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, China

Jonathan A Hill

1Surface Oncology, Inc. (acquired by Coherus BioSciences, Inc.), Cambridge, MA, USA

Vito J Palombella

1Surface Oncology, Inc. (acquired by Coherus BioSciences, Inc.), Cambridge, MA, USA

Robert R Haines

1Surface Oncology, Inc. (acquired by Coherus BioSciences, Inc.), Cambridge, MA, USA

Marisella Panduro

1Surface Oncology, Inc. (acquired by Coherus BioSciences, Inc.), Cambridge, MA, USA

James F Mohan

1Surface Oncology, Inc. (acquired by Coherus BioSciences, Inc.), Cambridge, MA, USA